Peking University Resources (Holdings) Company Limited (HKG:0618)
Hong Kong · Delayed Price · Currency is HKD 0.3450
-0.0300 (-8.00%)
Jul 31, 2026, 3:49 PM HKT
HKG:0618 Financials Overview
Financials in millions CNY. Fiscal year is April - March.
Millions CNY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,552 | 1,552 | 1,619 | 1,441 | 5,175 | 9,440 |
Revenue Growth | -7.57% | -4.14% | 12.32% | -72.15% | -45.18% | 3.90% |
Gross Profit Gross Profit Growth | 88.66 | 88.66 | -60.47 | 129.12 | 776.06 | 916.73 |
Operating Income Operating Income Growth | -184.48 | -184.48 | -2,156 | -459.37 | -2.21 | -17.29 |
Net Income Net Income Growth | 1,783 | 1,783 | -2,340 | -785.63 | 966.69 | 1,208 |
Earnings Per Share EPS Growth | 0.65 | 0.65 | -0.86 | -0.33 | 0.55 | 0.75 |
EPS Growth | 122.65% | - | - | - | -27.16% | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Medical and Pharmaceutical Retail Medical and Pharmaceutical Retail Growth | 155.07 | 155.07 | 190.76 | 87.81 | - | - |
Distribution of Information Products Distribution of Information Products Growth | 936.09 | 936.09 | 711.86 | 621.4 | 1,907 | 5,897 |
Property Development Property Development Growth | 377.35 | 377.35 | 605.23 | 558.2 | 3,220 | 3,466 |
Property Investment and Management Property Investment and Management Growth | 83.03 | 83.03 | 110.69 | 173.57 | 47.92 | 76.62 |
Total Total Growth | 1,552 | 1,552 | 1,619 | 1,441 | 5,175 | 9,440 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 301.99 | 301.99 | 601.4 | 890.2 | 696.11 | 1,385 |
Total Debt Total Debt Growth | 142.34 | 142.34 | 1,788 | 1,766 | 2,343 | 4,524 |
Net Cash (Debt) Net Cash Growth | 159.65 | 159.65 | -1,186 | -876.25 | -1,647 | -3,139 |
Net Cash Growth | 26.99% | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.06 | 0.06 | -0.44 | -0.37 | -0.93 | -1.96 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | - | -31.02 | -126.82 | -107.99 | -528.72 |
Capital Expenditures CapEx Growth | - | - | -17.19 | -11.27 | -7.5 | -7.08 |
Free Cash Flow Free Cash Flow Growth | - | - | -48.21 | -138.1 | -115.49 | -535.8 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 5.71% | 5.71% | -3.74% | 8.96% | 15.00% | 9.71% |
Operating Margin | -11.89% | -11.89% | -133.22% | -31.88% | -0.04% | -0.18% |
Pretax Margin | 105.95% | 105.95% | -151.77% | -51.55% | 30.85% | 2.05% |
Profit Margin | 114.95% | 114.95% | -144.57% | -54.52% | 18.68% | 12.79% |
FCF Margin | - | - | -2.98% | -9.58% | -2.23% | -5.68% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 0.47 | 0.40 | - | - | 0.99 | 0.70 |
PS Ratio | 0.54 | 0.46 | 0.24 | 0.46 | 0.19 | 0.09 |